Skip to main content
Caplight Logo









Alveo Technologies

Alveo Technologies

Private
Alameda, CaliforniaHealthcare & Life Scienceshttps://www.alveotechnologies.com/

Last Round

Grant

May 26, 2026

Total Funding Raised

$60.85M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Alveo Technologies is a biotechnology company that develops a portable, point-of-need molecular diagnostic platform for the rapid detection of infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Environmental Monitoring, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware + Subscription, Usage-Based SaaS, Government Contracts, Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

molecular diagnosticspoint-of-need testingrapid diagnosticspathogen detectiondecentralized diagnosticspoint-of-care testingPOC testingnucleic acid amplificationanimal health diagnosticsveterinary diagnosticsdisease surveillancebiosecurityassay developmentlab-on-a-chipagricultural diagnosticsfood safety testinghandheld analyzerAvian Influenza test

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alveo Technologies Comparables

Compare Alveo Technologies with similar companies based on industry and business-model similarity.

Alveo Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biomeme
85%
ProtonDx
84%
MatMaCorp
84%

Alveo Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 26, 2026
Series A ExtensionApr 29, 2025
GrantNov 14, 2024
Series BAug 1, 2023
VC RoundMar 29, 2021
Grant
Mar 17, 2021

Key People

Founding team and executive leadership

Slava Elagin

Chief Technology Officer

Executive Team

Alveo Technologies Investors

Notable investors and investment history

Alveo Technologies investors
InvestorRounds
Centers for Disease Control and PreventionGrant
CEPIGrant
H. Barton Asset ManagementSeries A Extension
Khosla VenturesGrant
WRVI CapitalSeries A, Series A Extension
Supply Change CapitalSeries A Extension
Bill & Melinda Gates FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 122, 21.8x the trailing average.

  • Apr 29, 2025

    Raised Series A Extension with Black Diamond Ventures, H. Barton Asset Management, WRVI Capital, and Supply Change Capital.

Alveo Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Alveo Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alveo Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersAlameda, California
Employee Range66
Year Founded2014
Last FundingMay 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?